Mr. Bian also commented, "To confront H1N1 influenza, Linkwell's 90%-held subsidiary, Likang Company, as a professional disinfectant supplier, contributes actively and responsibly. In the first half of this year, bottled disinfectants sent to most of hospitals around the country increased by tens of thousands, owing to the H1N1 disease. Due to last year's Wenchuan Earthquake in China, Likang was ordered by China's Ministry of Health to provide to the disaster areas a large amount of disinfectant, of which more than 400 tons were transported by air due to urgent need.

"We are carrying out R&D on new types of disinfectant to combat the influenza virus," Chairman Xuelian Bian emphasized, "Over the past few years, Likang has focused on the medical disinfection market in China, rejecting offers of cooperation from institutional investors who have wanted to invest in the civilian public health market many times. Nevertheless, the situation of the outbreak of infectious diseases throughout the world is becoming more urgent. China's 1.3 billion people make up a more than 30 billion market shares in the huge market of infection control. To Likang company, which holds a large number of civilian disinfection product technology patents, the decision to penetrate the civil disinfection market and other related markets will not only provide the most professional products and services to the whole community, but also lead to rapid growth and expansion for the company."

Source: linkwell